Regulatory, clinical, and commercial strategy
How she helps founders
Kelly develops and executes commercialization strategies for startups by aligning regulatory, clinical, and reimbursement pathways with their ultimate business objectives, whether that is scaling for sustainable growth or positioning for a successful exit. She helps founders develop their go to market story, as a way to support fundraising activities. She is an expert in global market entry, negotiating regulatory pathways with FDA, and supporting acquisition ready quality management systems and design history file assets.
Track record
Kelly was formerly a Director at NAMSA, leading global teams across Regulatory, Quality, and Medical Writing. She spent nearly a decade with Stryker developing regulatory strategies inside new product development teams and managing M&A activities from due diligence through full integration after acquisition.
Background
Kelly holds a B.S. in Chemical Engineering and has held Regulatory Affairs Certification (RAC) since 2013. She loves demystifying the complexities of the regulatory landscape and serving as a strategic ally so every milestone aligns with a client's commercial goals. She is an outdoor enthusiast, avid gardener, and a collector of toddler art.